Application of natural amino acid beta-aminoisobutyric acid in improvement of developmental potential and quality of oocytes

By adding β-aminoisobutyric acid (BAIBA) to the in vitro culture medium of oocytes, the problem of insufficient development potential and quality of oocytes under factors such as polycystic ovarian syndrome, advanced age and obesity was solved, and maturity was significantly improved and cell mass, improving mitochondrial function and ROS levels.

CN118879618APending Publication Date: 2024-11-01NANJING MATERNITY & CHILD HEALTH CARE HOSPITAL
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411001424.X
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-07-25
Publication Date
2024-11-01

AI Technical Summary

Technical Problem

The existing technology is difficult to effectively improve the development potential and quality of oocytes. Especially in oocyte culture under the influence of polycystic ovary syndrome, advanced age and obesity, the maturation rate and quality are insufficient, resulting in reproductive dysfunction and pregnancy difficulties. .

Method used

β-aminoisobutyric acid (BAIBA) is used as a natural small molecule β amino acid and added to the in vitro culture medium of oocytes, especially in M16 culture medium, with a concentration controlled between 0.01 and 3 μg/ml, which is used to increase the concentration. maturation rate and mass of oocytes.

Benefits of technology

By adding BAIBA in vitro culture, the maturation rate and MII formation rate of oocytes in GV phase were significantly improved, mitochondrial content was increased, mitochondrial membrane potential was improved, reactive oxygen species (ROS) level was reduced, and oocytes were significantly improved developmental potential and quality.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118879618A_ABST
    Figure CN118879618A_ABST
Patent Text Reader

Abstract

The invention belongs to the field of assisted reproduction, and particularly relates to application of natural amino acid in promoting maturation of oocytes. Application of natural amino acid in preparation of an in-vitro reagent for promoting oocyte development; and the natural amino acid is selected from BAIBA. By adding BAIBA to culture oocytes, the maturation rate and quality of the oocytes can be remarkably improved. Therefore, a new theoretical basis is provided for in-vitro culture and development research of oocytes.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the field of assisted reproduction, and in particular to the application of BAIBA in improving the developmental potential and quality of oocytes. Background Art

[0002] Amino acids are a class of amphoteric organic compounds containing alkaline amino groups and acidic carboxyl groups. They are the basic building blocks of biological functional macromolecule proteins. According to the different positions of the amino group on the carbon chain, amino acids can be divided into α-, β-, γ- and other amino acids. Amino acids enter cells through a series of special systems. In organisms, they are raw materials for the manufacture of antibody proteins, hemoglobin, enzyme proteins, hormone proteins, neurotransmitter substances, etc. They can even be used to provide energy sources for organisms and play an important role in cell function. There are a large number of amino acid transport systems in oocytes, indicating that they have the ability to utilize amino acids in the external environment. For example: Glutamine is considered to be an effective energy substrate to support oocyte development. For example, the use of glutamine as the only energy source is sufficient to initiate meiotic resumption of mouse oocytes in COC, although it cannot proceed through the MII stage. Adding glutamine to the culture medium can promote the maturation of bovine, hamster, dog, rabbit and rhesus monkey oocytes. Glutamine, aspartic acid and valine can also prevent polyspermia fertilization of porcine oocytes.

[0003] β-Aminoisobutyric acid (BAIBA) is a natural small molecule β-amino acid with a molecular weight of 103.6 Da. It has the advantages of simple structure, low cost, and flexible administration routes. BAIBA exists naturally in follicular fluid, so its role in oocyte maturation and early preimplantation embryo development has attracted our attention. Summary of the invention

[0004] The present invention demonstrates a new function of a natural amino acid, namely, BAIBA improves the developmental potential and quality of oocytes.

[0005] Another object of the present invention is to provide applications of BAIBA.

[0006] Another object of the present invention is to provide an oocyte culture medium containing BAIBA.

[0007] Use of BAIBA in the preparation of in vitro reagents for oocyte development.

[0008] As a preferred embodiment of the present invention, the concentration of BAIBA in the in vitro reagent is 0.01-3 μg / ml.

[0009] As a further preferred embodiment of the present invention, the concentration of BAIBA in the in vitro reagent is 0.08-1.2 μg / ml.

[0010] As a further preferred embodiment of the present invention, the concentration of BAIBA in the in vitro reagent is 0.8-1 μg / ml.

[0011] As a further preferred embodiment of the present invention, the in vitro reagent is the M16 culture medium in which the BAIBA is added.

[0012] As a preferred embodiment of the present invention, the oocytes are selected from oocytes of infertile patients, oocytes of patients with polycystic ovary syndrome, oocytes of elderly women, and oocytes of obese women.

[0013] A culture medium for culturing oocytes in vitro, comprising a basic culture medium M16 and BAIBA; the concentration of the BAIBA is 0.01-3 μg / ml.

[0014] As a preferred embodiment of the present invention, the concentration of BAIBA is 0.08-1.2 μg / ml.

[0015] As a further preferred embodiment of the present invention, the concentration of BAIBA in the in vitro reagent is 0.8-1 μg / ml.

[0016] The beneficial effects of the present invention are: The present invention discovered a new function of BAIBA and also provided a new theoretical basis for the study of oocyte culture in vitro.

[0017] The present invention added BAIBA at 1 μg / ml to GV stage oocytes obtained from PCOS mice, aged mice, and obese mice in vitro cultured M16 culture medium, and found that the addition of BAIBA can increase the maturation rate (MII formation rate) of GV stage oocytes with statistical significance.

[0018] BAIBA was added to the GV stage oocytes obtained from ICR mice at 1 μg / ml in vitro culture M16 medium. It was found that the addition of BAIBA could significantly increase the mitochondrial content, improve the mitochondrial membrane potential, and reduce the ROS level in mouse oocytes. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] Figure 1 Effects of BAIBA supplementation on oocyte development in PCOS model mice.

[0020] Difference in oocyte development rate of PCOS mice after adding optimal concentration of BAIBA. t-test: * indicates P < 0.05, ** indicates P < 0.01, *** indicates P < 0.001.

[0021] Figure 2 Effect of adding BAIBA on oocyte development in aged model mice.

[0022] Differences in oocyte development rate in aged mice after adding optimal concentration of BAIBA. t-test: * indicates P < 0.05, ** indicates P < 0.01.

[0023] Figure 3 Effects of BAIBA supplementation on oocyte development in obese mouse model.

[0024] Difference in oocyte development rate of mice fed a high-fat diet after adding the optimal concentration of BAIBA. t-test: * indicates P < 0.05, ** indicates P < 0.01.

[0025] Figure 4 Effect of BAIBA supplementation on mouse oocyte quality.

[0026] Differences in ICR mouse oocyte quality-related indicators after adding the optimal concentration of BAIBA. t-test: * indicates P < 0.05, ** indicates P < 0.01. DETAILED DESCRIPTION

[0027] The mice used in the examples were purchased from the Animal Experiment Center of Nanjing Medical University and all underwent safety quarantine.

[0028] Other reagents and equipment used were commercially available products.

[0029] Example 1 PCOS is an important cause of disease affecting female fertility, with a global incidence of 6%-21% among women. [1] The ovary is the main affected organ, which is manifested by reproductive dysfunction such as increased number of small follicles and immature oocytes, failure of dominant follicle selection, and ovulation disorders. Although the pregnancy rate of patients can be improved by improving lifestyle, using drug treatment and assisted reproductive technology, the quality of oocytes, embryos and pregnancy outcomes are still unsatisfactory. Therefore, we selected GV stage oocytes of PCOS mouse model for culture.

[0030] (1) Construction of PCOS mouse model: 3-week-old female ICR mice were selected, adaptively fed for 1 week, and randomly divided into testosterone propionate modeling group (PCOS) and solvent soybean oil control group (oil injection). PCOS mouse model: 50 μl of testosterone propionate solution (1 mg testosterone propionate) was continuously injected subcutaneously at the back of the neck of the mice, and they were fed a high-fat diet for a total of 21 days; solvent soybean oil control group: 50 μl of soybean oil solution was continuously injected subcutaneously at the back of the neck of the mice, and they were fed a normal diet for a total of 21 days. The experimental treated female mice and the solvent soybean oil control group female mice were all raised in a standardized SPF-level experimental animal facility.

[0031] (2) Prepare M16 culture medium containing 1 μg / ml BAIBA, and prepare M16 culture dishes with BAIBA added, with 30 μl per drop; prepare KSOM culture medium containing 1 μg / ml BAIBA, and prepare KSOM culture dishes with BAIBA added, with 30 μl per drop. Equilibrate in an incubator overnight.

[0032] (3) Obtaining and culturing GV-stage oocytes: Ovarian tissues were obtained from PCOS model mice and control mice, and the ovaries were minced with an egg chopper until they were minced. Large and three-dimensional GV-stage oocytes were selected under a microscope and placed in M16 culture medium containing 1 μg / ml BAIBA for in vitro maturation culture. 20-30 oocytes were placed in each culture drop, and the germinal vesicle rupture (GVBD) was observed after 3 h of culture, and the first polar body discharge (MII formation) was observed after 14 h.

[0033] Compared with PCOS mouse oocytes, the MII formation rate was significantly increased after adding 1 μg / ml BAIBA (43% vs 33%, p=0.003) and the difference was statistically significant. Figure 1 ) Example 2 Acquisition and culture of oocytes from aged mice With the implementation of the policy of encouraging childbearing and the influence of the concept of late marriage and late childbearing, the proportion of elderly pregnant women in my country is increasing day by day, and the contradiction between reproductive aging and fertility needs has begun to become prominent. Reproductive aging is the key reason for the decline in fertility. In addition to the decrease in the number of follicles, the quality of eggs and embryos also gradually declines, which in turn leads to an increase in the incidence of embryo arrest, spontaneous abortion and birth defects. Therefore, how to improve the impact of reproductive aging on fertility has become a major issue that needs to be urgently addressed in the field of reproductive health in my country. Mice aged 10 to 14 months are equivalent to 38-47 years old in humans, so we chose the GV stage oocytes of the elderly mouse model (10 months old, 10M) for culture.

[0034] (1) Aged mouse model: 10-month-old ICR female mice were selected as the aged group. Age-appropriate mouse control group: 8-week-old (8W) ICR female mice. The experiment can be started after one week of adaptive feeding.

[0035] (2) Prepare M16 culture medium containing 1 μg / ml BAIBA, and prepare M16 culture dishes with BAIBA added, with 30 μl per drop; prepare KSOM culture medium containing 1 μg / ml BAIBA, and prepare KSOM culture dishes with BAIBA added, with 30 μl per drop. Equilibrate in an incubator overnight.

[0036] (3) Obtaining and culturing GV-stage oocytes: Ovarian tissues were obtained from aged model mice and control mice, and the ovaries were minced with an egg chopper until they were minced. Large and three-dimensional GV-stage oocytes were selected under a microscope and placed in M16 culture medium containing 1 μg / ml BAIBA for in vitro maturation culture. 20-30 oocytes were placed in each culture drop, and the germinal vesicle rupture (GVBD) was observed after 3 h of culture, and the first polar body discharge (MII formation) was observed after 14 h.

[0037] Compared with aged mice, the MII formation rate of oocytes in the group supplemented with 1 μg / ml BAIBA was significantly increased (65% vs 28%, p=0.029), with statistically significant difference ( Figure 2 ).

[0038] Example 3 Obese mouse oocyte acquisition and culture In 2021, the World Health Organization released a global population health report, and the global obesity rate has increased nearly three times since 1975, exceeding 650 million people. From 1975 to 2016, there were more than 1.9 billion overweight adults aged 18 and over, accounting for 39% of the adult population (39% of men and 40% of women), of which more than 650 million were obese, accounting for 13% of the adult population (11% of men and 15% of women). Obesity has become a global epidemic, gradually damaging human health. The number of people who die from overweight and obesity worldwide is far greater than the number of people who die from underweight. With the prevalence of obesity, the proportion of obesity in women of childbearing age is also continuing to rise, and it has a serious impact on women's reproductive health. Obesity has been reported to cause oocyte meiotic arrest, loss of mitochondrial and endoplasmic reticulum function, and abnormal changes in epigenetic modifications, and the corresponding mechanisms have gradually been revealed. Therefore, we chose the GV stage oocytes of the obese mouse model for culture.

[0039] (1) Construction of obese mouse model Three-week-old female ICR mice were selected and adaptively fed for 1 week, and then randomly divided into a high-fat diet group (HFD) and a control group (ND). High-fat diet-fed mouse model: fed a high-fat diet for 10 weeks; control mice: fed a normal diet. Both the experimental treated female mice and the control female mice were raised in a standardized SPF-level experimental animal facility.

[0040] (2) Configuring the M16 culture system containing myogenic factors UV irradiation fume hood half an hour in advance. Prepare M16 culture medium containing 1 μg / ml BAIBA in the fume hood, prepare M16 culture dishes with BAIBA added, 30 μl per drop, and balance in the incubator overnight.

[0041] (3) Obtaining and culturing GV-stage oocytes: Ovarian tissues were obtained from aged model mice and control mice, and the ovaries were minced with an egg chopper until they were minced. Large and three-dimensional GV-stage oocytes were selected under a microscope and placed in M16 culture medium containing 1 μg / ml BAIBA for in vitro maturation culture. 20-30 oocytes were placed in each culture drop, and the germinal vesicle rupture (GVBD) was observed after 3 h of culture, and the first polar body discharge (MII formation) was observed after 14 h.

[0042] Compared with the normal diet-fed group, the GVBD formation rate (86% vs 65%, p=0.02) and MII formation rate (66% vs 43%, p=0.018) of the oocytes of the obese mice (high-fat diet-fed) group supplemented with 1μg / ml BAIBA were significantly increased ( Figure 3 ).

[0043] Example 4 Normal ICR mouse oocyte acquisition, culture and quality assessment (1) Age-appropriate mouse control group: 8-week-old ICR female mice. The experiment can be started after one week of adaptive feeding.

[0044] (2) Prepare M16 culture medium containing 1 μg / ml BAIBA, and prepare M16 culture dishes with BAIBA added, with 30 μl per drop; prepare KSOM culture medium containing 1 μg / ml BAIBA, and prepare KSOM culture dishes with BAIBA added, with 30 μl per drop. Equilibrate in an incubator overnight.

[0045] (3) Obtaining and culturing GV-stage oocytes: Ovarian tissues were obtained from aged model mice and control mice, and the ovaries were minced with an egg chopper until they were minced. Large and three-dimensional GV-stage oocytes were selected under a microscope and placed in M16 culture medium containing 1 μg / ml BAIBA for in vitro maturation culture. 20-30 oocytes were placed in each culture drop, and the germinal vesicle rupture (GVBD) was observed after 3 h of culture, and the first polar body discharge (MII formation) was observed after 14 h.

[0046] (4) MII stage oocytes from the control group and the BAIBA group were collected and the mitochondria in the oocytes were labeled with MitoTracker Green mitochondrial green fluorescent probe. Then, the mitochondrial content and distribution in the oocytes were observed using a laser confocal microscope. The fluorescence intensity was measured and statistically analyzed. The results showed that the mitochondrial fluorescence intensity of the oocytes in the BAIBA group was higher than that in the control group (69.94317 VS 38.59874, p<0.0001).

[0047] The mitochondria in oocytes were labeled with JC-1 fluorescent probe, and then the fluorescence intensity of JC-1 polymers (red) and JC-1 monomers (green) in oocytes was observed using a laser confocal microscope. The fluorescence intensity was measured and the ratio between the two was statistically analyzed to reflect the changes in mitochondrial membrane potential and measure mitochondrial depolarization. The results showed that the JC-1 polymers / monomers in the mitochondria of oocytes in the BIABA group were higher than those in the control group (0.452988 VS 0.229915, p=0.0158).

[0048] The reactive oxygen species (ROS) level in oocytes was labeled with DCFH-DA fluorescent probe, and then the fluorescence intensity of ROS in oocytes was observed using laser confocal microscopy, and the fluorescence intensity was measured and statistically analyzed. The results showed that the level of reactive oxygen species in oocytes in the BIABA group was significantly lower than that in the control group (10.13472 VS26.67417, p<0.0001).

Claims

1. Application of BAIBA in the preparation of in vitro reagents for promoting oocyte development.

2. The use according to claim 1, characterized in that The concentration of BAIBA in the in vitro reagent is 0.01-3 μg / ml.

3. The use according to claim 1, characterized in that The concentration of BAIBA in the in vitro reagent is 0.08-1.2 μg / ml.

4. The use according to claim 3, characterized in that The concentration of BAIBA in the in vitro reagent is 0.8-1 μg / ml.

5. The use according to any one of claims 1 to 4, characterized in that The in vitro reagent is prepared by adding BAIBA to M16 culture medium.

6. The use according to claim 5, characterized in that The oocytes are selected from oocytes of infertile patients, oocytes of patients with polycystic ovary syndrome, oocytes of elderly women, and oocytes of obese women.

7. A culture medium for culturing oocytes in vitro, characterized in that Basic culture medium and BAIBA; the concentration of BAIBA is 0.01-3 μg / ml.

8. The culture medium according to claim 7, characterized in that The concentration of BAIBA is 0.08~1.2μg / ml.

9. The culture medium according to claim 8, characterized in that The concentration of BAIBA is 0.8~1μg / ml.